Cytori Therapeutics to Webcast 2006 4th Quarter and Year End Results on March 30, 2007.SAN DIEGO -- Cytori Therapeutics, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CYTX) (Frankfurt:XMPA XMPA X-ray Electron Microprobe Analysis XMPA Extensible Media Protection Architecture ) will release financial results for the quarter and year ended December 31, 2006 on Friday, March 30 at approximately 9:00 a.m. Eastern Daylight Time (EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT ) or 6:00 p.m. Central European Summer Time Central European Summer Time (CEST) is one of the names of UTC+2 time zone, 2 hours ahead of Coordinated Universal Time. It is used as a summer daylight saving time in most European and some North African countries. During the winter, Central European Time (UTC+1) is used. (CEST). The company's management will host a conference call at 10:00 a.m. (EDT) or 7:00 p.m. (CEST) to discuss the results. The audio webcast of the conference call may be accessed under "Events & Webcasts" in the Investor Relations Investor relations The process by which the corporation communicates with its investors. section of the Company's website at www.cytoritx.com. The webcast will be available live and by replay two hours after the call on the company's website and archived for 90 days. A telephone replay will be available for one week. To access the replay, please call +1 (303) 590-3000 (PIN: 11086131#). About Cytori Therapeutics Cytori Therapeutics, Inc. (NASDAQ:CYTX) (Frankfurt:XMPA) is developing and seeks to commercialize stem and regenerative cell therapies for cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease , reconstructive surgery and many other serious chronic, and life threatening conditions. To provide these therapies, physicians remove a small amount of a patient's fat, also known as adipose tissue, and run it through Cytori's Celution[TM] System. This System quickly separates and concentrates stem and regenerative cells from adipose tissue so they may be quickly administered back to the patient about an hour later. This system will dramatically improve the way in which personalized cell-based therapies can be delivered to patients. http://cytoritx.com |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion